BEN-MAIMON CAROLE
SEC CIK 1529611 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | Pres, CEO, Dir | 368.3K | $118.5K | — | 6 | 2022-09-16 | 2026-01-26 |
Most active insiders at LRMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | $25.00M | — |
| 2 | Hamilton Thomas Edward | Dir | $666.9K | — |
| 3 | THOMAS FRANK E | Dir | $25.0K | — |
| 4 | SHERMAN JEFFREY W | Dir | $25.0K | — |
| 5 | Shankar Gopi | Chief Development Off | — | — |
| 6 | Clayton Russell | Chief Medical Off | — | — |
| 7 | BEN-MAIMON CAROLE | Pres, CEO, Dir | — | — |
| 8 | Celano Michael | CFO | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-27 | 2026-01-26 | LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | Pres, CEO, Dir | A - Grant | $0.00 | +100.1K | 368.3K | +37% | $0 |
| D | 2025-01-24 | 2025-01-22 | LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | Pres, CEO, Dir | A - Grant | $0.00 | +91.0K | 387.2K | +31% | $0 |
| D | 2024-01-19 | 2024-01-17 | LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | Pres, CEO, Dir | A - Grant | $0.00 | +66.1K | 333.0K | +25% | $0 |
| 2023-05-18 | 2023-05-17 | LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | Pres, CEO, Dir | P - Purchase | $3.71 | +5,000 | 266.8K | +2% | +$18.6K | |
| D | 2023-02-02 | 2023-01-31 | LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | Pres, CEO, Dir | A - Grant | $0.00 | +205.0K | 261.8K | +361% | $0 |
| 2022-09-19 | 2022-09-16 | LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | Pres, CEO, Dir | P - Purchase | $3.15 | +31.7K | 56.8K | +127% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations